| Abstract |
In this issue of Cancer Cell, She et al. show that in cancer cells a protein called 4E-BP1 is a key integrator of protein synthesis downstream of the ERK and AKT signaling pathways, providing an intriguing rationale for why their simultaneous targeting could enhance therapeutic efficacy. |
| Authors | Steven Whittaker, Matthew Martin, Richard Marais |
| Journal | Cancer cell
(Cancer Cell)
Vol. 18
Issue 1
Pg. 5-6
(Jul 13 2010)
ISSN: 1878-3686 [Electronic] United States |
| PMID | 20609347
(Publication Type: Comment, Journal Article)
|
| Copyright | Copyright (c) 2010 Elsevier Inc. All rights reserved. |
